ArticleClinical and translational radiation oncology2026
Indication adherence and outcome of post-operative radiotherapy in oral cavity cancer patients with intermediate adverse pathological tumor features: A nationwide population-based analysis.
Article in Clinical and translational radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The significance of intermediate-risk adverse pathological features in oral squamous cell carcinoma (OSCC) remains unclear. Consequently, the indications for postoperative radiotherapy (PORT) vary between hospitals. This study evaluates treatment patterns and outcomes of PORT for OSCC patients with intermediate-risk adverse pathological features in a real-world national cohort. Materials and methods: All first primary OSCC patients (n = 683) with intermediate-risk adverse pathological features from the tumor treated between 2018 and 2021 in the Netherlands were included. Features were 1-5 mm resection margins, pT3-T4 classification, perineural invasion, worst pattern of invasion (WPOI) 4-5, or vaso-invasive growth. Odds ratios (ORs) for receiving PORT were calculated using multivariable regression analysis. Hospital variation was assessed using funnel plots. Two-year overall survival (OS) and local control (LC) were evaluated using multivariable Cox regression analysis. Results: The percentage of patients receiving PORT increased when more features were present (4.0% for 1 feature, 67% for all features). Significant predictors for PORT were pT3-T4 (OR 23.3), 1-5 mm margin (OR 3.72), WPOI 4-5 (OR 1.83) and perineural invasion (OR4.75). Patients with vaso-invasive growth (OR 0.19) and increasing age (OR 0.96) received PORT less often. Hospital differences in PORT treatment remained after correction for confounders. PORT did not significantly improve the adjusted hazard ratio for LC (1.56, p = 0.36) and OS (0.55, p = 0.08). Conclusion: Of the tumor-related pathological features, pT3-pT4 contributed the most to PORT treatment in OSCC. Significant hospital differences remained after correction for confounding factors. Future research should focus on guideline consensus to prevent over- and undertreatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.